BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14607941)

  • 41. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
    Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME
    Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unique Roles for
    Wooten AK; Shenoy AT; Arafa EI; Akiyama H; Martin IMC; Jones MR; Quinton LJ; Gummuluru S; Bai G; Mizgerd JP
    Front Immunol; 2020; 11():554. PubMed ID: 32300347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Female resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic target.
    Yang Z; Huang YC; Koziel H; de Crom R; Ruetten H; Wohlfart P; Thomsen RW; Kahlert JA; Sørensen HT; Jozefowski S; Colby A; Kobzik L
    Elife; 2014 Oct; 3():. PubMed ID: 25317947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-1 promotes coagulation, which is necessary for protective immunity in the lung against Streptococcus pneumoniae infection.
    Yang H; Ko HJ; Yang JY; Kim JJ; Seo SU; Park SG; Choi SS; Seong JK; Kweon MN
    J Infect Dis; 2013 Jan; 207(1):50-60. PubMed ID: 23100560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.
    Reppe K; Tschernig T; Lührmann A; van Laak V; Grote K; Zemlin MV; Gutbier B; Müller HC; Kursar M; Schütte H; Rosseau S; Pabst R; Suttorp N; Witzenrath M
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):474-81. PubMed ID: 18931326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia.
    Schultz MJ; Wijnholds J; Peppelenbosch MP; Vervoordeldonk MJ; Speelman P; van Deventer SJ; Borst P; van der Poll T
    J Immunol; 2001 Mar; 166(6):4059-64. PubMed ID: 11238654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of pulmonary innate immunity during bacterial infection: animal studies.
    Schultz MJ; van der Poll T
    Arch Immunol Ther Exp (Warsz); 2002; 50(3):159-67. PubMed ID: 12098931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia.
    Knapp S; Hareng L; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; Hartung T; van der Poll T
    J Infect Dis; 2004 Apr; 189(8):1506-15. PubMed ID: 15073689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ASC and NLRP3 impair host defense during lethal pneumonia caused by serotype 3 Streptococcus pneumoniae in mice.
    van Lieshout MHP; de Vos AF; Dessing MC; de Porto APNA; de Boer OJ; de Beer R; Terpstra S; Florquin S; Van't Veer C; van der Poll T
    Eur J Immunol; 2018 Jan; 48(1):66-79. PubMed ID: 28971472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The contraction phase of virus-specific CD8+ T cells is unaffected by a pan-caspase inhibitor.
    Nussbaum AK; Whitton JL
    J Immunol; 2004 Dec; 173(11):6611-8. PubMed ID: 15557151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The innate immune response to pneumococcal lung infection: the untold story.
    Kadioglu A; Andrew PW
    Trends Immunol; 2004 Mar; 25(3):143-9. PubMed ID: 15036042
    [No Abstract]   [Full Text] [Related]  

  • 52. Earliest innate immune responses require macrophage RelA during pneumococcal pneumonia.
    Pittet LA; Quinton LJ; Yamamoto K; Robson BE; Ferrari JD; Algül H; Schmid RM; Mizgerd JP
    Am J Respir Cell Mol Biol; 2011 Sep; 45(3):573-81. PubMed ID: 21216972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia.
    van der Sluijs KF; Nijhuis M; Levels JH; Florquin S; Mellor AL; Jansen HM; van der Poll T; Lutter R
    J Infect Dis; 2006 Jan; 193(2):214-22. PubMed ID: 16362885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Air pollution particles diminish bacterial clearance in the primed lungs of mice.
    Sigaud S; Goldsmith CA; Zhou H; Yang Z; Fedulov A; Imrich A; Kobzik L
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):1-9. PubMed ID: 17561223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arginase 1 activity worsens lung-protective immunity against Streptococcus pneumoniae infection.
    Knippenberg S; Brumshagen C; Aschenbrenner F; Welte T; Maus UA
    Eur J Immunol; 2015 Jun; 45(6):1716-26. PubMed ID: 25789453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary dendritic cells and alveolar macrophages are regulated by gammadelta T cells during the resolution of S. pneumoniae-induced inflammation.
    Kirby AC; Newton DJ; Carding SR; Kaye PM
    J Pathol; 2007 May; 212(1):29-37. PubMed ID: 17370296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia.
    Lagler H; Sharif O; Haslinger I; Matt U; Stich K; Furtner T; Doninger B; Schmid K; Gattringer R; de Vos AF; Knapp S
    J Immunol; 2009 Aug; 183(3):2027-36. PubMed ID: 19596984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C-type Lectin Mincle Recognizes Glucosyl-diacylglycerol of Streptococcus pneumoniae and Plays a Protective Role in Pneumococcal Pneumonia.
    Behler-Janbeck F; Takano T; Maus R; Stolper J; Jonigk D; Tort Tarrés M; Fuehner T; Prasse A; Welte T; Timmer MS; Stocker BL; Nakanishi Y; Miyamoto T; Yamasaki S; Maus UA
    PLoS Pathog; 2016 Dec; 12(12):e1006038. PubMed ID: 27923071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.
    Kerr AR; Paterson GK; Riboldi-Tunnicliffe A; Mitchell TJ
    Infect Immun; 2005 Jul; 73(7):4245-52. PubMed ID: 15972516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease.
    Ramos-Sevillano E; Urzainqui A; de Andrés B; González-Tajuelo R; Domenech M; González-Camacho F; Sánchez-Madrid F; Brown JS; García E; Yuste J
    PLoS Pathog; 2016 Mar; 12(3):e1005500. PubMed ID: 26975045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.